Nephrotoxicity of first generation cephalosporins: considerations on experimental and clinical pharmacology.
D000617:Aminoglycosides / Q000494:pharmacology; D000818:Animals; D002509:Cephaloridine / Q000009:adverse effects; D002511:Cephalosporins / Q000008:administration & dosage / Q000633:toxicity*; D002512:Cephalothin / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D007239:Infections / Q000188:drug therapy; D007275:Injections, Intravenous; D007684:Kidney Tubules / Q000187:drug effects*; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D007928:Lethal Dose 50
D000617:Aminoglycosides; D002511:Cephalosporins; D002509:Cephaloridine; D002512:Cephalothin